In 2010, Cofactor Genomics and Knome Inc analysed Osbourne’s genome using a then-state-of-the-art platform, to understand how his body had withstood what should have been a fatal lifestyle. They looked at genes related to metabolism, addiction and neurobiology – what they found was deeply intriguing.


